Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aims: Whether and when glomerular filtration rate (GFR) in preterms catches up with term peers is unknown. This study aims to develop a GFR maturation model for (pre)term-born individuals from birth to 18 years of age. Secondarily, the function is applied to data of different renally excreted drugs.

Methods: We combined published inulin clearance values and serum creatinine (Scr) concentrations in (pre)term born individuals throughout childhood. Inulin clearance was assumed to be equal to GFR, and Scr to reflect creatinine synthesis rate/GFR. We developed a GFR function consisting of GFR (GFR at birth), and an Emax model dependent on PNA (with GFR, PNA (PNA at which half of is reached) and Hill coefficient). The final GFR model was applied to predict gentamicin, tobramycin and vancomycin concentrations.

Result: In the GFR model, GFR varied with birthweight linearly while in the PNA-based Emax equation, GA was the best covariate for PNA, and current weight for GFR. The final model showed that for a child born at 26 weeks GA, absolute GFR is 18%, 63%, 80%, 92% and 96% of the GFR of a child born at 40 weeks GA at 1 month, 6 months, 1 year, 3 years and 12 years, respectively. PopPK models with the GFR maturation equations predicted concentrations of renally cleared antibiotics across (pre)term-born neonates until 18 years well.

Conclusions: GFR of preterm individuals catches up with term peers at around three years of age, implying reduced dosages of renally cleared drugs should be considered below this age.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024008PMC
http://dx.doi.org/10.1007/s11095-024-03677-3DOI Listing

Publication Analysis

Top Keywords

gfr
15
glomerular filtration
8
filtration rate
8
catches term
8
term peers
8
gfr maturation
8
inulin clearance
8
gfr model
8
child born
8
renally cleared
8

Similar Publications

Introduction: The residual risk of chronic kidney disease (CKD) progression remains high in clinical trials of kidney protective drugs in patients with diabetic kidney disease (DKD).

Methods: In a prospective study, we assessed whether 16 plasma and 10 urine cytokine levels can inform the residual risk of CKD progression in 93 incident patients with DKD treated by Nephrology according to clinical guidelines.

Results: Plasma and urine levels of 12 plasma and 7 urinary cytokines differed between patients with DKD and from healthy controls.

View Article and Find Full Text PDF

SIRT1 modulation and lipid profile alterations in the cellular regulation of blood lipids in renal disorders among extremely obese individuals.

Cell Mol Biol (Noisy-le-grand)

September 2025

University Sousse, Faculty of Medicine "Ibn El-Jazzar", Department of Medical Genetics, Sousse, Tunisia.

The global epidemic of overweight and obesity is closely linked to the development of chronic kidney disease (CKD), with extremely obese individuals facing a particularly high risk. This study aimed to assess the relationship between lipid profile levels, SIRT1 expression, and RNA-34a-5P in the regulation of blood lipid levels among severely obese individuals with renal diseases. Conducted over six months in three specialized hospitals, the study included 100 participants divided into two groups: 50 obese individuals with renal diseases and 50 obese controls without renal problems.

View Article and Find Full Text PDF

Introduction: Tumour-induced osteomalacia (TIO) is rare. At our referral centre, we see a substantial number of TIO. Therefore, we planned to study their profile and treatment outcomes to provide insight in management.

View Article and Find Full Text PDF

A Drug-Wide Association Study on Medications Associated With Cystatin C Estimated GFR.

Am J Kidney Dis

September 2025

Department of Population Health Sciences, Geisinger, Danville, PA; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.

View Article and Find Full Text PDF

Objectives: This report examines the role of age-specific trends in fertility rates in the decline in the number of births and of general fertility rates (GFRs) and total fertility rates (TFRs).

Methods: Data are from the National Center for Health Statistics' National Vital Statistics System birth data files from 1990 through 2023. To estimate the role of changes in age-specific fertility rates on total births, GFRs, and TFRs from 1990 through 2023, 1990 rates for each maternal age category were kept constant and applied to all subsequent years to produce adjusted totals and rates.

View Article and Find Full Text PDF